Discover
ANIX
Anixa Biosciences, Inc.
2.90
2 x 2.09
2 x 3.71
bid
ask
-
0.01
0.34%
2 @ 04:00 PM
2.90 +0.00 (0.00%)
| Ytd | -7.05% | |
| 1y | -41.06% |
2.86
day range
2.96
2.35
52 week range
5.22
| Open | 2.93 | Prev Close | 2.91 | Low | 2.86 | High | 2.96 | Mkt Cap | 100.82M |
| Vol | 217.88K | Avg Vol | 302.95K | EPS | -0.32 | P/E | N/A | Forward P/E | -7.17 |
| Beta | 0.85 | Short Ratio | 3.03 | Inst. Own | 17.46% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 09-09 | 50-d Avg | 3.13 | 200-d Avg | 3.00 | 1yr Est | 8.50 |
| Income Statement | |||
| Operating Expenses | 2.74M | ||
| Research and Development Expense | 1.33M | ||
| Selling, General and Administrative Expense | 1.41M | ||
| Operating Income | -2.74M | ||
| Net Income | -2.61M | ||
| Net Income Common Stock | -2.61M | ||
| Net Income Common Stock (USD) | -2.61M | ||
| Consolidated Income | -2.62M | ||
| Net Income to Non-Controlling Interests | -19.00K | ||
| Earnings per Basic Share | -0.08 | ||
| Earnings per Basic Share (USD) | -0.08 | ||
| Earnings per Diluted Share | -0.08 | ||
| Earning Before Interest & Taxes (EBIT) | -2.61M | ||
| Earning Before Interest & Taxes (USD) | -2.61M | ||
| Weighted Average Shares | 34.18M | ||
| Weighted Average Shares Diluted | 34.18M | ||
| Balance Sheet | |||
| Cash and Equivalents | 1.40M | ||
| Cash and Equivalents (USD) | 1.40M | ||
| Investments | 12.47M | ||
| Investments Current | 12.47M | ||
| Current Assets | 14.91M | ||
| Property, Plant & Equipment Net | 163.00K | ||
| Total Assets | 15.07M | ||
| Debt Current | 46.00K | ||
| Total Debt | 174.00K | ||
| Current Liabilities | 1.75M | ||
| Debt Non-Current | 128.00K | ||
| Total Liabilities | 1.87M | ||
| Accumulated Retained Earnings (Deficit) | -259.36M | ||
| Shareholders Equity | 14.47M | ||
| Shareholders Equity (USD) | 14.47M | ||
| Assets Non-Current | 163.00K | ||
| Total Debt (USD) | 174.00K | ||
| Liabilities Non-Current | 128.00K | ||
| Trade and Non-Trade Payables | 282.00K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 10.00K | ||
| Net Cash Flow from Financing | 1.94M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -79.00K | ||
| Issuance (Purchase) of Equity Shares | 1.94M | ||
| Net Cash Flow from Investing | -245.00K | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -245.00K | ||
| Net Cash Flow from Operations | -1.77M | ||
| Share Based Compensation | 666.00K | ||